Bioton S.A. (BIO)
GPW
Real-time Data
07:00 AM
Day's Range
3.6852 wk Range
3.65Overview - BIO - Bioton S.A.
Key Statistics
Valuation
Enterprise Value
379.84M
P/E (Trailing)
‪75.40‬
PEG Ratio
‪4.83‬
Price / Sales (TTM)
‪1.21‬
Price / Book
‪0.54‬
EV / EBITDA
‪7.27‬
Profitability
Gross Margin
‪29.49%‬
Profit Margin
‪1.52%‬
Operating Margin
‪-8.39%‬
Return on Assets
‪1.08%‬
Return on Equity
‪0.69%‬
Ownership
Shares Outstanding
85.86M
Float
38.79M
Held by Insiders
‪56.30%‬
Held by Institutions
‪0.27%‬
Price stats
Beta
‪0.17‬
50-Day Avg
‪3.88‬
200-Day Avg
‪4.05‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BIO - Bioton S.A.
Peers - BIO - Bioton S.A.
Peer Comparison
Compared with companies in Biotechnology listed on GPW.
Profile Summary - BIO - Bioton S.A.
About
Bioton S.A. is a Polish biotechnology company specializing in the development, manufacturing, and distribution of recombinant human insulin and generic pharmaceuticals. Headquartered in Macierzysz near Warsaw, the company is among the first four organizations globally capable of producing recombinant human insulin, a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
